# Mattias Ankarberg

> Mattias Ankarberg is a venture - series unknown investor at Byggmax backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Byggmax](https://shizune.co/investors/profile/byggmax)
- Location: Stockholm, Sweden
- Total investments: 1
- Last investment: Jan 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/mattias-ankarberg-00173/?originalSubdomain=se

Mattias Ankarberg is a venture - series unknown investor at Byggmax in Stockholm focused on Biotechnology and Medical Device. Mattias Ankarberg

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sigrid Therapeutics | Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics. | $1M | Venture - Series Unknown | Jan 16, 2023 |  |

1 of 1 investments shown.

## About Byggmax

VC Fund · Solna, Sweden

Byggmax Group AB is a Sweden-based company active within the construction materials retail sector. The Company is engaged in the discount retail of construction materials in the Nordic do-it-yourself (DIY) market. Its offering includes basic construction materials, such as wood, stone and concrete, isolation materials, doors, windows, flooring,paints and coatings, tools, screws, bolts, basic electrical and ventilation materials, kitchen and toilet fittings, as well as wooden cottage sets.

3 contacts available at Byggmax.

| Name | Title | Profile |
| --- | --- | --- |
| Magnus Agervald | Founder | https://shizune.co/investors/profile/magnus-agervald-d27f |
| Mattias Ankarberg | Chief Executive Officer | https://shizune.co/investors/profile/mattias-ankarberg |
| Stig Notlov | Founder | https://shizune.co/investors/profile/stig-notlov |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors in Sweden](https://shizune.co/investors/medical-device-angel-investors-sweden)
- [Biotech Angel Investors in Sweden](https://shizune.co/investors/biotech-angel-investors-sweden)

## FAQ

### What does Mattias Ankarberg invest in?

Mattias Ankarberg invests primarily in Biotechnology and Medical Device startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mattias Ankarberg last invest?

The most recent investment recorded for Mattias Ankarberg closed in Jan 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co